Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study
Status:
Terminated
Trial end date:
2018-03-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether it is possible to give 8 doses of a combination
of chemotherapy called FOLFIRINOX before surgery in subjects whose pancreas cancer can be
removed with surgery.